Linked Life Data

15080818

Source:http://linkedlifedata.com/resource/pubmed/id/15080818

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-4-14
pubmed:abstractText
Patients with severe asthma are often inadequately controlled on existing anti-asthma therapy, constituting an unmet clinical need.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0954-7894
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
632-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:15080818-Adolescent, pubmed-meshheading:15080818-Adult, pubmed-meshheading:15080818-Aged, pubmed-meshheading:15080818-Androstadienes, pubmed-meshheading:15080818-Anti-Asthmatic Agents, pubmed-meshheading:15080818-Antibodies, Anti-Idiotypic, pubmed-meshheading:15080818-Antibodies, Monoclonal, pubmed-meshheading:15080818-Antibodies, Monoclonal, Humanized, pubmed-meshheading:15080818-Asthma, pubmed-meshheading:15080818-Bronchodilator Agents, pubmed-meshheading:15080818-Child, pubmed-meshheading:15080818-Double-Blind Method, pubmed-meshheading:15080818-Drug Administration Schedule, pubmed-meshheading:15080818-Drug Therapy, Combination, pubmed-meshheading:15080818-Female, pubmed-meshheading:15080818-Humans, pubmed-meshheading:15080818-Immunoglobulin E, pubmed-meshheading:15080818-Male, pubmed-meshheading:15080818-Middle Aged, pubmed-meshheading:15080818-Quality of Life, pubmed-meshheading:15080818-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
pubmed:affiliation
RCMB Research Division, Southampton General Hospital, Southampton, UK. sth@soton.ac.uk
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study